Abstract No. 150 ▪ Featured Abstract Multimodal Imageable Eye90 microspheres Radioembolization for Hepatocellular Carcinoma: 6-Month Interim Safety and Efficacy and 3-Month Liver Volume Results from a First-in-Human Trial

To describe 6-month safety and efficacy and 3-month liver volume changes after multimodal imageable glass Y-90 radioembolization for hepatocellular carcinoma (HCC) in a first-in-human clinical trial.

Source: Journal of Vascular and Interventional Radiology : JVIR - February 21, 2024 Category: Radiology Authors: R. Abraham, A. Verma, D. Dobrowski, S. Kappadath, D. Liu, A. Holden, A. Arepally Source Type: research